TrialCephalalgia : an international journal of headache2020

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.

David W Dodick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.